Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003462,
    "name": "Nureca",
    "stock_name": "Nureca",
    "full_name": "Nureca Ltd",
    "name_url": "stocks-analysis/nureca",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "277.90",
    "chg": 2.5,
    "chgp": "0.91%",
    "dir": 1,
    "prev_price": "275.40",
    "mcapval": "265.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543264,
    "symbol": "NURECA",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE0DSF01015",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "13.99 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nureca’s Market Assessment Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-financials-3737588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Nureca_mojoScore_3737588.png",
        "date": "2025-12-01 08:08:51",
        "description": "Nureca, a player in the healthcare services sector, has experienced a notable shift in its market evaluation following recent developments across technical indicators, financial performance, valuation metrics, and long-term fundamentals. This article analyses the factors influencing the revised market assessment of Nureca, highlighting key data points and contextualising them within broader market trends."
      },
      {
        "title": "How has been the historical performance of Nureca?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nureca-3736018",
        "imagepath": "",
        "date": "2025-11-28 22:42:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance Trends</strong></p>\n<p>Over the six-year period ending March 2025, Nureca's net sales exhibited notable volatility. The company recorded a peak revenue of ₹255.55 crores in March 2022, followed by a sharp decline to ₹109.66 crores in March 2025. This fluctuation reflects a challenging market environment or strategic shifts impacting sales volumes and pricing. Total operating income mirrored this pattern, with no other operating income reported during the period.</p>\n<p>Cost management has been a mixed bag. Raw material costs, introduced in recent years, rose to ₹11.29 crores by March 2025, while purchases of finished goods remained the largest expenditure, peaking at ₹159.55 crores in March 2022 before falling to ₹63.68 crores in March 2025. The company also..."
      },
      {
        "title": "Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-surges-on-extraordinary-buying-interest-hits-upper-circuit-amid-no-sellers-3735463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Nureca_only_buyers_3735463.png",
        "date": "2025-11-28 10:50:35",
        "description": "Nureca Ltd has witnessed extraordinary buying momentum, registering a strong 4.99% gain today with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. This surge outpaces the broader Sensex, reflecting robust investor enthusiasm in the healthcare services sector."
      },
      {
        "title": "Nureca Ltd Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-shares-surge-to-upper-circuit-amid-robust-buying-pressure-3735389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Nureca_stocks_hitting_upper_circuit_3735389.png",
        "date": "2025-11-28 10:00:39",
        "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, witnessed robust market activity as its stock hit the upper circuit price limit on 28 Nov 2025. The surge was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and broader market indices."
      },
      {
        "title": "Why is Nureca falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nureca-fallingrising-3734380",
        "imagepath": "",
        "date": "2025-11-28 00:41:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Momentum and Market Outperformance</strong></p>\n<p>The stock has demonstrated notable short-term strength, gaining 7.55% over the past week compared to a marginal 0.10% rise in the Sensex. This recent rally includes a three-day consecutive gain, during which Nureca’s shares appreciated by 10.93%. On 27-Nov, the stock opened with a gap up of 4.26% and reached an intraday high of ₹280.75, outperforming its sector, Medical Equipment/Supplies/Accessories, which itself rose by 2.93%. Furthermore, Nureca is trading above all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—signalling a strong technical uptrend.</p>\n<p><strong>Robust Quarterly Financial Performance</strong></p>\n<p>Underlying this price appreciation is the company’s very positive quarterly performance..."
      },
      {
        "title": "Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3733645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Nureca_stocks_hitting_upper_circuit_3733645.png",
        "date": "2025-11-27 12:00:14",
        "description": "Nureca Ltd, a player in the healthcare services sector, witnessed its shares hit the upper circuit price limit on 27 Nov 2025, reflecting robust buying interest and a surge in market activity. The stock closed at ₹275.85, marking a daily gain of 4.99%, outperforming its sector and broader market indices amid heightened investor participation and a regulatory trading freeze."
      },
      {
        "title": "Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-3731082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Nureca_stocks_hitting_upper_circuit_3731082.png",
        "date": "2025-11-26 10:00:48",
        "description": "Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, surged to hit the upper circuit limit on 26 Nov 2025, reflecting robust investor demand and a notable reversal after a week of declines. The stock closed at ₹262.75, marking a 5.0% gain on the day and outperforming its sector peers significantly."
      },
      {
        "title": "Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-surges-to-upper-circuit-on-unprecedented-buying-interest-amid-market-volatility-3730695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Nureca_only_buyers_3730695.png",
        "date": "2025-11-26 09:36:21",
        "description": "Nureca Ltd has witnessed extraordinary buying momentum today, registering a sharp 4.98% gain and hitting an intraday high of Rs 267.5. The stock’s trading activity is marked by an absence of sellers, resulting in a rare upper circuit scenario that could extend over multiple sessions as demand continues to outstrip supply."
      },
      {
        "title": "Why is Nureca falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nureca-fallingrising-3713388",
        "imagepath": "",
        "date": "2025-11-18 23:37:31",
        "description": "As of 18-Nov, Nureca Ltd's stock price is currently at 266.00, reflecting a decrease of 5.2 points or 1.92%. The stock has been experiencing a downward trend, having fallen for the last two consecutive days with a total decline of 3.1% during this period. Despite the company reporting very positive results, including a significant net profit growth of 348.15% and a rise in promoter confidence with a 0.64% increase in stake, the stock has underperformed against the benchmark indices. Over the past week, Nureca's stock has decreased by 1.77%, while the Sensex has gained 0.96%. Additionally, the stock's liquidity appears to be declining, with a notable drop in delivery volume by 95.18% compared to the five-day average.\n\nIn the broader market context, Nureca's performance has been consistently weaker than the benchmark, with a year-to-date return of -5.66% compared to the Sensex's 8.36% gain. The medical equipm..."
      }
    ],
    "total": 232,
    "sid": "1003462",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/nureca-1003462"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
      "datetime": "31-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal Aryan Goyal Payal Goyal Smita Goyal & Nectar Biopharma Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22",
          "dt": "2022-02-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nureca’s Market Assessment Shifts Amid Mixed Financial and Technical Signals

2025-12-01 08:08:51

Nureca, a player in the healthcare services sector, has experienced a notable shift in its market evaluation following recent developments across technical indicators, financial performance, valuation metrics, and long-term fundamentals. This article analyses the factors influencing the revised market assessment of Nureca, highlighting key data points and contextualising them within broader market trends.

How has been the historical performance of Nureca?

2025-11-28 22:42:59

Revenue and Operating Performance Trends Over the six-year period ending March 2025, Nureca's net sales exhibited notable volatility. The company recorded a peak revenue of ₹255.55 crores in March 2022, followed by a sharp decline to ₹109.66 crores in March 2025. This fluctuation reflects a challenging market environment or strategic shifts impacting sales volumes and pricing. Total operating income mirrored this pattern, with no other operating income reported during the period. Cost management has been a mixed bag. Raw material costs, introduced in recent years, rose to ₹11.29 crores by March 2025, while purchases of finished goods remained the largest expenditure, peaking at ₹159.55 crores in March 2022 before falling to ₹63.68 crores in March 2025. The company also...

Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-28 10:50:35

Nureca Ltd has witnessed extraordinary buying momentum, registering a strong 4.99% gain today with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. This surge outpaces the broader Sensex, reflecting robust investor enthusiasm in the healthcare services sector.

Nureca Ltd Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum

2025-11-28 10:00:39

Nureca Ltd, a micro-cap player in the Healthcare Services sector, witnessed robust market activity as its stock hit the upper circuit price limit on 28 Nov 2025. The surge was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and broader market indices.

Why is Nureca falling/rising?

2025-11-28 00:41:15

Short-Term Price Momentum and Market Outperformance The stock has demonstrated notable short-term strength, gaining 7.55% over the past week compared to a marginal 0.10% rise in the Sensex. This recent rally includes a three-day consecutive gain, during which Nureca’s shares appreciated by 10.93%. On 27-Nov, the stock opened with a gap up of 4.26% and reached an intraday high of ₹280.75, outperforming its sector, Medical Equipment/Supplies/Accessories, which itself rose by 2.93%. Furthermore, Nureca is trading above all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—signalling a strong technical uptrend. Robust Quarterly Financial Performance Underlying this price appreciation is the company’s very positive quarterly performance...

Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum

2025-11-27 12:00:14

Nureca Ltd, a player in the healthcare services sector, witnessed its shares hit the upper circuit price limit on 27 Nov 2025, reflecting robust buying interest and a surge in market activity. The stock closed at ₹275.85, marking a daily gain of 4.99%, outperforming its sector and broader market indices amid heightened investor participation and a regulatory trading freeze.

Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure

2025-11-26 10:00:48

Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, surged to hit the upper circuit limit on 26 Nov 2025, reflecting robust investor demand and a notable reversal after a week of declines. The stock closed at ₹262.75, marking a 5.0% gain on the day and outperforming its sector peers significantly.

Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-26 09:36:21

Nureca Ltd has witnessed extraordinary buying momentum today, registering a sharp 4.98% gain and hitting an intraday high of Rs 267.5. The stock’s trading activity is marked by an absence of sellers, resulting in a rare upper circuit scenario that could extend over multiple sessions as demand continues to outstrip supply.

Why is Nureca falling/rising?

2025-11-18 23:37:31

As of 18-Nov, Nureca Ltd's stock price is currently at 266.00, reflecting a decrease of 5.2 points or 1.92%. The stock has been experiencing a downward trend, having fallen for the last two consecutive days with a total decline of 3.1% during this period. Despite the company reporting very positive results, including a significant net profit growth of 348.15% and a rise in promoter confidence with a 0.64% increase in stake, the stock has underperformed against the benchmark indices. Over the past week, Nureca's stock has decreased by 1.77%, while the Sensex has gained 0.96%. Additionally, the stock's liquidity appears to be declining, with a notable drop in delivery volume by 95.18% compared to the five-day average. In the broader market context, Nureca's performance has been consistently weaker than the benchmark, with a year-to-date return of -5.66% compared to the Sensex's 8.36% gain. The medical equipm...

View All News